International Journal of Infectious Diseases
Volume 13, Issue 6 , Pages 701-706 , November 2009

Bladder irrigation with amphotericin B and fungal urinary tract infection—systematic review with meta-analysis

  • Felipe Francisco Tuon

      Affiliations

    • Department of Infectious and Parasitic Diseases, Hospital das Clínicas, Faculdade de Medicina da Universidade de São Paulo, Avenida Dr. Enéas de Carvalho Aguiar 255, 4 andar. Sala 4028 – ICHC, Cerqueira Cesar, CEP 05403-010, São Paulo, Brazil
    • Clinic of Infectious and Parasitic Diseases, Hospital Universitário Evangelico de Curitiba, Curitiba, PR, Brazil
    • Corresponding Author InformationCorresponding author. Tel.: +55 11 30696530; fax: +55 11 30697508.
  • ,
  • Valdir Sabbaga Amato

      Affiliations

    • Infectious and Parasitic Diseases Clinic, Hospital das Clínicas, School of Medicine, University of Sao Paulo, SP, Brazil
  • ,
  • Sergio Ricardo Penteado Filho

      Affiliations

    • Clinic of Infectious and Parasitic Diseases, Hospital Universitário Evangelico de Curitiba, Curitiba, PR, Brazil

Received 24 April 2008 ,Revised 8 September 2008 ,Accepted 20 October 2008.

  • Image Result

    Selection of the studies included in the meta-analysis of the use of amphotericin B bladder irrigation in the treatment of asymptomatic candiduria.

    Selection of the studies included in the meta-analysis of the use of amphotericin B bladder irrigation in the treatment of asymptomatic candiduria.

  • Image Result

    Comparison between amphotericin B bladder irrigation (intermittent or continuous) and fluconazole in the treatment of asymptomatic candiduria. The relative risk is related to candiduria persistence. T

    Comparison between amphotericin B bladder irrigation (intermittent or continuous) and fluconazole in the treatment of asymptomatic candiduria. The relative risk is related to candiduria persistence. The upper graph shows the evaluation of urine culture 24hours after therapy and the lower graph shows the evaluation of urine culture 1 week after therapy.

PII: S1201-9712(08)01739-6

doi: 10.1016/j.ijid.2008.10.012

International Journal of Infectious Diseases
Volume 13, Issue 6 , Pages 701-706 , November 2009